CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults

Atopic dermatitis (AD) is a condition frequently encountered in medical practices across the country. Arming ourselves with appropriate and safe treatment modalities to provide relief for this chronic and relapsing inflammatory condition is of utmost importance to our patients and their families. Ut...

Descripción completa

Detalles Bibliográficos
Autores principales: Segal, Audrey O, Ellis, Anne K, Kim, Harold L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707742/
https://www.ncbi.nlm.nih.gov/pubmed/23837743
http://dx.doi.org/10.1186/1710-1492-9-24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707742/
https://www.ncbi.nlm.nih.gov/pubmed/23837743
http://dx.doi.org/10.1186/1710-1492-9-24

Ejemplares similares